Methodology for Anti-Cryptococcal Vaccine Development.
Ashok K Chaturvedi1,2, Floyd L Wormley3,4
1Department of Biology, University of Texas at San Antonio, One UTSA Circle, San Antonio, TX, 78249-0062, USA.
Methods in Molecular Biology (Clifton, N.J.)
|June 7, 2017
Summary
This study details a method to find fungal proteins from Cryptococcus neoformans and Cryptococcus gattii that trigger a strong immune response. Identifying these antigens is key for developing new vaccines against cryptococcosis.
Area of Science:
- Mycology
- Immunology
- Infectious Diseases
Background:
- Cryptococcus neoformans and Cryptococcus gattii cause cryptococcosis, ranging from pneumonia to central nervous system infections.
- Cell-mediated immunity (CMI) involving T-helper 1 CD4+ T cells is crucial for host defense against these fungal pathogens.
- Current vaccines for cryptococcosis are not standardized, despite identified antigens eliciting cellular responses.
Purpose of the Study:
- To describe a methodology for screening and isolating cryptococcal proteins.
- To identify antigens that induce protective immune responses against cryptococcosis.
Main Methods:
- Screening of cryptococcal proteins to assess their immunogenicity.
- Isolation of proteins that elicit protective CMI.
Main Results:
- Identification of specific cryptococcal antigens that stimulate potent cellular immune responses.
- Potential candidates for subunit vaccine development were identified.
Conclusions:
- A standardized methodology can effectively screen for cryptococcal antigens that induce protective immunity.
- These identified antigens are promising for developing novel subunit vaccines against cryptococcosis.
